Krebs, F.S.; Moura, B.; Missiaglia, E.; Aedo-Lopez, V.; Michielin, O.; Tsantoulis, P.; Bisig, B.; Trimech, M.; Zoete, V.; Homicsko, K.
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. Int. J. Mol. Sci. 2023, 24, 4520.
https://doi.org/10.3390/ijms24054520
AMA Style
Krebs FS, Moura B, Missiaglia E, Aedo-Lopez V, Michielin O, Tsantoulis P, Bisig B, Trimech M, Zoete V, Homicsko K.
Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. International Journal of Molecular Sciences. 2023; 24(5):4520.
https://doi.org/10.3390/ijms24054520
Chicago/Turabian Style
Krebs, Fanny Seraphine, Bianca Moura, Edoardo Missiaglia, Veronica Aedo-Lopez, Olivier Michielin, Petros Tsantoulis, Bettina Bisig, Mounir Trimech, Vincent Zoete, and Krisztian Homicsko.
2023. "Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma" International Journal of Molecular Sciences 24, no. 5: 4520.
https://doi.org/10.3390/ijms24054520
APA Style
Krebs, F. S., Moura, B., Missiaglia, E., Aedo-Lopez, V., Michielin, O., Tsantoulis, P., Bisig, B., Trimech, M., Zoete, V., & Homicsko, K.
(2023). Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma. International Journal of Molecular Sciences, 24(5), 4520.
https://doi.org/10.3390/ijms24054520